These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6496196

  • 1. Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.
    Guggiari M, Dagreou F, Rivierez M, Mottet P, Gallais S, Philippon J, Viars P.
    Acta Neurochir (Wien); 1984; 73(1-2):25-33. PubMed ID: 6496196
    [Abstract] [Full Text] [Related]

  • 2. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
    Schisano G, Franco A, Nina P, Papa ML, Iannuzzi M, De Biase R, Caldora M.
    J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of cerebrospinal fluid fibrinolytic activity in meningeal hemorrhages as a result of aneurysm rupture].
    Rivierez M, Dagreou F, Guggiari M, Ankri A, Crespo B, Philippon J.
    Neurochirurgie; 1983 Jun; 29(2):119-23. PubMed ID: 6888630
    [Abstract] [Full Text] [Related]

  • 4. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
    Fodstad H, Pilbrant A, Schannong M, Strömberg S.
    Acta Neurochir (Wien); 1981 Jun; 58(1-2):1-13. PubMed ID: 7282453
    [Abstract] [Full Text] [Related]

  • 5. Cisternal and lumbar CSF levels of arachidonate metabolites after subarachnoid haemorrhage: an assessment of the biochemical hypothesis of vasospasm.
    Rodriguez y Baena R, Gaetani P, Silvani V, Viganò T, Crivellari MT, Paoletti P.
    Acta Neurochir (Wien); 1987 Jun; 84(3-4):129-35. PubMed ID: 3107348
    [Abstract] [Full Text] [Related]

  • 6. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
    Fodstad H, Nilsson IM.
    Acta Neurochir (Wien); 1981 Jun; 56(1-2):25-38. PubMed ID: 7195642
    [Abstract] [Full Text] [Related]

  • 7. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
    Maurice-Williams RS, Gordon YB, Sykes A.
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
    [Abstract] [Full Text] [Related]

  • 8. [Coagulation-fibrinolytic abnormality and symptomatic vasospasm in the acute stage of ruptured cerebral aneurysms--analysis of alpha 2 PI, alpha 2 PIC, FDP and D.dimer].
    Shibahashi H, Yamaura A.
    No To Shinkei; 1991 Mar; 43(3):239-46. PubMed ID: 1830749
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F, D'angelo V, Collice M, Ferrara M, Donati MB, Porta M.
    Eur Neurol; 1978 Mar; 17(1):43-7. PubMed ID: 624294
    [Abstract] [Full Text] [Related]

  • 10. Arachidonate metabolites and vasospasm after subarachnoid haemorrhage.
    Rodriguez y Baena R, Gaetani P, Folco G, Viganó T, Paoletti P.
    Neurol Res; 1986 Mar; 8(1):25-32. PubMed ID: 2871506
    [Abstract] [Full Text] [Related]

  • 11. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
    Steinmetz H, Grote E.
    Neurol Res; 1983 Mar; 5(4):59-65. PubMed ID: 6149487
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products.
    Sawaya R, Sonnino V, McLaurin RL, Perrotta G.
    J Neurosurg; 1983 May; 58(5):699-707. PubMed ID: 6834119
    [Abstract] [Full Text] [Related]

  • 13. [Studies on the fibrinolytic system in ruptured intracranial aneurysm.--Part 2: Fibrinogen changes in acute stage of SAH as a risk factor of the ischemic complications following vasospasm (author's transl)].
    Watanabe H, Ishii S, Matsuda T.
    No Shinkei Geka; 1978 Jun; 6(6):563-9. PubMed ID: 673136
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
    Woszczyk A, Deinsberger W, Böker DK.
    Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
    [Abstract] [Full Text] [Related]

  • 17. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
    Vermeulen M, van Vliet HH, Lindsay KW, Hijdra A, van Gijn J.
    J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
    [Abstract] [Full Text] [Related]

  • 18. CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients.
    Kaye AH, Tagari PC, Teddy PJ, Adams CB, Blaso WP, Boullin DJ.
    J Neurosurg; 1984 May; 60(5):927-34. PubMed ID: 6716160
    [Abstract] [Full Text] [Related]

  • 19. Relation of cerebral vasospasm to operative findings of subarachnoid blood around ruptured aneurysms.
    Tomasello F, Albanese V, Picozzi P, Spadaro A, Conforti P.
    Acta Neurochir (Wien); 1982 May; 60(1-2):55-62. PubMed ID: 7058700
    [Abstract] [Full Text] [Related]

  • 20. [Fibrinolytic activity of cerebrospinal fluid as an indicator of the risk of repeated ruptures of arterial aneurysms].
    Kholodov SA, Shelkovskiĭ VN, Platonova TK.
    Zh Vopr Neirokhir Im N N Burdenko; 1985 May; (4):18-22. PubMed ID: 4050242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.